Authors
Loading...
Cross-sectional analysis confirms effectiveness of Ceftazidime-avibactam/Aztreonam synergy against NDM strains, implying potential for treating resistant infections.
Rajan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: